Therapeutics News and Research

RSS

Brown, Insight Therapeutics partnership to accelerate research on flu vaccines for older adults

With support from a three-year $2.1 million agreement with Insight Therapeutics, a private company that focuses on the health care of older adults, a team of Brown University public health researchers will look to identify the most effective flu vaccines for elderly nursing home residents.

14 Dec 2019

Neuroscientists develop new method for uniquely targeted gene therapy

Neuroscientists at Lund University in Sweden have developed a new technology that engineers the shell of a virus to deliver gene therapy to the exact cell type in the body that needs to be treated. The researchers believe that the new technology can be likened to dramatically accelerating evolution from millions of years to weeks.

13 Dec 2019

Influenza research could pave way for new and improved drugs, vaccines

Researchers at the Centenary Institute and the University of Sydney have discovered a key reason as to why the influenza virus is so effective at establishing infection and causing damage in the lungs.

13 Dec 2019

Impulsive eating could stem from certain regions of the brain

Weight loss mandates healthy eating and control of impulses when it comes to eating fat rich and processed foods. The actual story is quite different, as most persons on a diet have found out the hard way. The smell of food and even thoughts have given rise to binge eating, indulging in excessive food intake that has led to obesity and weight gain.

12 Dec 2019

Scientists discover specific neurons that promote reward-like behaviors, alcohol consumption

Scientists have known that a region of the brain called the central nucleus of the amygdala (CeA) plays a role in behaviors related to alcohol use and consumption in general. It's been less known which precise populations of brain cells and their projections to other brain regions mediate these behaviors.

12 Dec 2019

Study shows unexpected mechanism for lipid acquisition by breast cancer cells

High-fat diets and obesity have been shown to increase the risk of breast cancer and worsen outcomes and prognosis of breast cancer patients. A team of researchers from Dartmouth and Dartmouth-Hitchcock Norris Cotton Cancer Center led by William Kinlaw III, MD, sought to understand how fat from the diet might influence breast cancer cells.

12 Dec 2019

Specific brain circuit linked to food impulsivity discovered

You're on a diet, but the aroma of popcorn in the movie theater lobby triggers a seemingly irresistible craving.

11 Dec 2019

IONTAS antibody for the treatment of B-Cell ALL receives approval for clinical trials

IONTAS Limited, a leader in the discovery and optimization of fully human antibodies, has been informed that International Biotechnology Center Generium, a leading Russian biopharmaceutical company, focused on developing and commercializing pharmaceutical products for the treatment of orphan diseases and cancer, has received approval from the Russian Health Authorities to initiate clinical trials with its CD3/CD19 bispecific antibody for the treatment of B-Cell Acute Lymphoblastic Leukemia.

From FairJourney Biologics 11 Dec 2019

Legalization status of cannabis affects people's views on benefits

Residents of states where cannabis has been legalized are more likely to believe it has beneficial effects - including health benefits in treatment of pain and anxiety or depression, reports a survey study in the Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine.

10 Dec 2019

New joint venture aims to develop implantable cell therapies for debilitating conditions with no cure

Mayo Clinic and W. L. Gore & Associates Inc., a global materials science company, have formed a joint venture to advance the development of implantable cell therapies to treat debilitating conditions with no cure. Avobis Bio will combine Mayo Clinic's clinical and cell expertise and Gore's expertise in material sciences to address some of the most challenging medical issues.

10 Dec 2019

Researchers discover a widespread method used by phages to hide from bacterial defenses

University of Otago researchers have discovered how viruses that specifically kill bacteria can outwit bacteria by hiding from their defenses, findings which are important for the development of new antimicrobials based on viruses and provide a significant advance in biological knowledge.

10 Dec 2019

Innovative experimental therapy may stop growth of triple-negative breast cancer

Mount Sinai researchers have designed an innovative experimental therapy that may be able to stop the growth of triple-negative breast cancer, the deadliest type of breast cancer, which has few effective treatment options, according to a study published in Nature Chemical Biology in December.

9 Dec 2019

Groundbreaking technique could help predict a protein's interactions with other proteins

Proteins are the building blocks of life and play a key role in all biological processes. Understanding how they interact with their environment is therefore vital to developing effective therapeutics and the foundation for designing artificial cells.

9 Dec 2019

Important biomarker may help in determining prognosis of brain cancer patients

A common virus that is harmless to most individuals may produce an important biomarker in determining the prognosis of brain cancer patients, according to a recent study published by a student researcher at the University of Cincinnati.

9 Dec 2019

Next-generation sequencing can detect genetic alterations specific to follicular lymphoma

People with follicular lymphoma, a slow-growing lymphatic-system cancer, who have been treated and are in remission for at least two years, may no longer have what has been considered an incurable disease based on highly sensitive testing.

9 Dec 2019

Study shows safety of palbociclib for advanced breast cancer patients with unique gene alteration

Women who receive palbociclib (Ibrance) to treat their advanced breast cancer and have a gene alteration that can lead to a condition known as benign ethnic neutropenia (BEN), can safely receive the drug without major concerns of developing infections associated with neutropenia, or low white blood cell counts, say Georgetown Lombardi Comprehensive Cancer Center researchers.

9 Dec 2019

Therapeutics News and Research

Brown, Insight Therapeutics partnership to accelerate research on flu vaccines for older adults

Neuroscientists develop new method for uniquely targeted gene therapy

Influenza research could pave way for new and improved drugs, vaccines

Impulsive eating could stem from certain regions of the brain

Scientists discover specific neurons that promote reward-like behaviors, alcohol consumption

Study shows unexpected mechanism for lipid acquisition by breast cancer cells

Specific brain circuit linked to food impulsivity discovered

IONTAS antibody for the treatment of B-Cell ALL receives approval for clinical trials

Legalization status of cannabis affects people's views on benefits

New joint venture aims to develop implantable cell therapies for debilitating conditions with no cure

Researchers discover a widespread method used by phages to hide from bacterial defenses

Innovative experimental therapy may stop growth of triple-negative breast cancer

Groundbreaking technique could help predict a protein's interactions with other proteins

Important biomarker may help in determining prognosis of brain cancer patients

Next-generation sequencing can detect genetic alterations specific to follicular lymphoma

Study shows safety of palbociclib for advanced breast cancer patients with unique gene alteration

Common first-line treatment for cryptococcal meningitis in being compromised by drug resistance

Breakthrough research develops novel vaccine poised to cure peanut allergies

Common treatment for cryptococcal meningitis compromised by emergence of drug resistance

Genetically engineered living hydrogel material facilitates intestinal wound healing

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News